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Abstract 
Traditionally, surgery of the abdomen and pelvis has been through the open approach. However, with 
the advent of technological advancements, surgical specialities have embraced the benefits of 
minimally invasive surgery (MIS), both for the surgeon and the patient.  
With the early concepts of MIS dating as far back as 400 BC, and with the myriad of technological 
advancements, refinements in MIS has allowed patients to benefit from quicker recovery, 
convalescence and cosmesis. The many recognised benefits have meant that many procedures 
recognise MIS as the gold standard, including cholecystectomy, appendectomy and prostatectomy.  
However, even with these benefits patient selection remains important. Just because MIS can be 
performed doesn’t mean that it should always be performed, as certain patient groups are 
contraindicated and the need to convert to an open procedure loses all associated benefits of MIS.  
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Traditionally, surgery of the abdomen and pelvis has been through the open approach. However, with 
the advent of technological advancements, surgical specialities have embraced the benefits of 
minimally invasive surgery (MIS), both for the surgeon and the patient.  
History of minimally invasive surgery 
The first successful elective laparotomy was performed in 1809 by Ephraim McDowell to resect a 10.2 
kg ovarian tumour (Ellis 2015). Since then, open surgery, or a laparotomy of the abdomen, has 
remained the gold standard for many procedures, such as open nephrectomy for the management of 
small renal masses (2005).  
The early concepts of MIS originate as far back as Hippocrates, where in 400 BC, he detailed the use 
of a speculum to examine haemorrhoids (St. Peter and Holcomb 2008). The 19th century saw further 
developments at a light source, with Bozzini’s Lichtleiter (1806), Segalas’ urethro-cystique (1826) and 
Nitze’s kystoskop (1877) (St. Peter and Holcomb 2008). Bernheim reported the first laparoscopy (1911), 
and since then, there have been a myriad of development in technology and technique: 𝐶𝑂2 insufflation 
(1910); Veress’ spring loaded needle for induction of a pneumoperitoneum (1938); Kalk’s 135° lens 
(1929); Hopkins’ fibreoptic prototype (1954); and the Hasson technique for direct visualisation of port 
placement (1974) (St. Peter and Holcomb 2008). With these advancements, only now could MIS be 
more widely adopted, to offer patient benefits when compared to the previous standard of a laparotomy.  
Current status 
There are many procedures where the minimally invasive approach has become the new gold standard, 
or where it is not, is being used more frequently due to the associated benefits for the patient.  
Cholecystectomy is a very common procedure (NHS 2016), and the open approach has been the gold 
standard for over 100 years, with the laparoscopic alternative introduced in the 1980s (Keus et al. 2006). 
The National Institute of Health Consensus Development Conference (1992) found laparoscopic 
cholecystectomy to be preferential to the open technique (Gollan et al. 1993), and is now the gold 
standard (National Institute for Health and Care Excellence (NICE) 2014). A Cochrane Systematic 
Review (Keus et al. 2006), comparing laparoscopic and open cholecystectomy for patients with 
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symptomatic cholecystolithiasis found that there were no significant differences in mortality, 
complications and operative time between the two techniques, but found that the laparoscopic 
technique was associated with significantly shorter hospital stay and quicker convalescence.  
Open partial nephrectomies (OPN) remain the gold standard in the treatment of small renal masses. 
Despite this, at Royal Free Hospital, only 8% of all renal operations are through the open approach, 
and 12% laparoscopically and 80% robotically. This is due to the many associated patient benefits of 
MIS.  
Laparoscopic partial nephrectomy (LPN) has been shown to be as effective as the gold standard 
(Benidir et al. 2014), by offering comparable long-term oncological and functional outcomes (Cha et al. 
2011). LPN is associated with post-operative benefits for the patient (decreased blood loss, shorter 
length of stay, improved cosmesis and shorter convalescence) (Cha et al. 2011), however its use should 
be only by a surgeon experienced in the laparoscopic procedure.  
Robotic-assisted partial nephrectomy (RAPN) is a relatively new procedure, first described by Gettman 
et al. in 2004 (Gettman et al. 2004). Like LPN, its minimally invasive approach has many patient 
benefits. A comparative study between OPN, LPN and RAPN found that RAPN had shorter warm 
ischaemia time (WIT) than LPN (although the gold standard had the shortest); the lowest estimated 
blood loss; lower morbidity (intra and postoperative complications) than OPN; and lower rates of positive 
surgical margins than the gold standard (Porpiglia et al. 2016). In their study, trifecta was defined as 
the absence of perioperative complications, negative surgical margins and WIT < 25 minutes. They 
reported that this occurred in 62.4%, 63.2% and 69.0% for OPN, LPN and RAPN respectively, showing 
that the minimally invasive approaches were functionally and oncologically superior.  
Laparoscopic appendectomy has a significantly smaller incision compared to the open approach 
(Ruffolo et al. 2013). Its minimally invasiveness, in a recent Cochrane Systematic Review (Sauerland 
et al. 2010), was shown to be associated with reduced postoperative pain, reduced wound infection 
rate and a shorter time until return to normal activity, as well as better cosmesis. Minimally invasive 
surgery offers clear advantages and should be preferred in obese patients, older patients and patients 
with comorbidities (Di Saverio et al. 2016), which would make them poorer candidates for maximally 
invasive (open) surgery, which is often due to a reduced physiological reserve to recover from surgery.  
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Open radical prostatectomy has been the traditional approach (Ilic et al. 2017), but robotic assisted 
radical prostatectomy (RARP) has now become the gold standard in the treatment of localised prostate 
cancer (Mottet et al. 2015). A recent Cochrane Systematic Review (Ilic et al. 2017) found that 
laparoscopic radical prostatectomy and robotic assisted radical prostatectomy were similar to the gold 
standard in terms of urinary and sexual quality of life-related outcomes, and that differences in 
postoperative pain was minimal, but found that the minimally invasive approach had shorter length of 
stay and less blood loss when compared to the gold standard.   
When comparing a laparotomy to MIS, a large incision in the abdominal wall is replaced by several 
smaller incisions. This offers the patient better cosmesis, and though there may be a greater number 
of incisions, there has been development towards single port surgery (single incision laparoscopic 
surgery (SILS) and the Da Vinci SP (Intuitive Surgical, Inc, Sunnyvale, Calif)) ([CSL STYLE ERROR: 
reference with no printed form.]), or even hidden incisions (natural orifice transluminal endoscopic 
surgery (NOTES)).  
Benefits to the patient 
The many patient benefits associated with MIS, when compared to a laparotomy are due to the 
minimally invasive nature of the procedure. With smaller wounds, the patient can recover quicker, and 
achieve quicker convalescence, as shown by the Cochrane review for cholecystectomy. In the case of 
RAPN, it has even been shown to offer superior oncological outcomes when compared to the gold 
standard, and the significance of decreased WIT allows for preservation of functional renal parenchyma, 
improving the patient’s functional outcomes, alongside the associated decrease in total morbidity. 
Within appendectomy, the laparoscopic approach has been shown to be associated with reduced 
postoperative pain, reduced wound infection rate and a shorter convalescence, and is even preferred 
for patients who are poorer candidates for open surgery. With regards to radical prostatectomies, whilst 
achieving similar results to the gold standard in terms of urinary and sexual quality of life-related 
outcomes, the patient benefits from shorter length of stay and blood loss.  
Limitations of minimally invasive surgery 
There are certain contraindications to the use of MIS. Patients with physiological limitations (Bowers 
and Hunter) are poor candidates for MIS. Patients with severe hypovolaemia may not compensate well 
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and may experience a large fall in cardiac output following insufflation. The Trendelenburg position and 
insufflation can also increase intracranial pressure (ICP), and is therefore contraindicated in patients 
with an already elevated ICP, and in those with glaucoma 
The patient benefits of MIS can be lost when there are laparoscopic entry access injuries. A study 
looking at claims arising from US and non-US entry access injuries (Chandler et al. 2001), found that 
the most commonly reported injuries were that to the small bowel and iliac artery. With any form of 
internal injury, such as an uncontrolled rate of bleeding, and the limited accessibility through the 
minimally invasive nature, there will be times when there is a need to convert to a laparotomy. As such, 
the patient loses all associated benefits of MIS once this is performed. So, whilst MIS offers many 
potential benefits, it is important for the surgeon to consult the patient about the associated risks as 
well, and the potential need to convert to an open procedure.  
As MIS is relatively new, compared to the pre-existing gold standard laparotomy in many procedures, 
long-term follow up will be required to effectively prove that the new minimally invasive approaches are 
able to offer superior oncological outcomes (in the case of cancer) when compared to the current gold 
standard. This is because most MIS procedures have already been shown to be safe and feasible as 
they can be performed, and they have already shown, even in early findings, to offer superior functional 
outcomes to a laparotomy.  
Conclusion  
The benefits of performing MIS over a laparotomy is that often, equal oncological outcomes are 
achieved, whilst achieving superior functional outcomes, which means that the patient is able to gain 
more from the procedure. Even with these benefits, patient selection still remains important in ensuring 
that the patient will benefit as much as they can from the MIS. Just because MIS can be performed 
does not mean that it should be performed on all patients, as outlined by the potential limitations of MIS 
in certain patient groups and the associated risk of complications. Overall, for many patients, MIS is 
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